Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/12/2007EP1863814A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
12/12/2007EP1863813A2 Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogs thereof, and methods
12/12/2007EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
12/12/2007EP1863811A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
12/12/2007EP1863810A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1' RECEPTOR LIGANDS
12/12/2007EP1863809A2 Pyrazolopyridines and analogs thereof
12/12/2007EP1863808A1 Gaboxadol forms, compositions thereof, and related methods
12/12/2007EP1863807A1 'n-(2-chloro-6-methylphenyl)-2-ýý6-ý4-(2-hydroxyethyl)-1-piperazinyl¨-2-methyl-4-pyrimidinyl¨amino¨-5-thiazolecarboxamides metabolites
12/12/2007EP1863806A1 Amorphous ziprasidone mesylate
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863804A1 Inhibitors of histone deacetylase
12/12/2007EP1863803A2 Substituted piperidines
12/12/2007EP1863802A1 Substituted piperidines as renin inhibitors
12/12/2007EP1863801A2 Benzimidazole derivative and use thereof
12/12/2007EP1863800A2 Synthesis of avrainvillamide, stephacidin b, and analogues thereof
12/12/2007EP1863798A1 Indole derivatives
12/12/2007EP1863797A1 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY
12/12/2007EP1863796A1 Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use
12/12/2007EP1863795A1 Substituted triazole derivatives as oxytocin antagonists
12/12/2007EP1863794A2 Pyrimidine compounds and methods of use
12/12/2007EP1863793A2 Hepatitis c virus inhibitors
12/12/2007EP1863792A1 Atp competitive kinase inhibitors
12/12/2007EP1863791A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
12/12/2007EP1863790A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
12/12/2007EP1863789A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
12/12/2007EP1863788A1 A novel crystalline form of rupatadine free base
12/12/2007EP1863787A1 Hydogrenated benzo[c]thiophene derivatives as immunomodulators
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
12/12/2007EP1863784A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
12/12/2007EP1863782A1 2-(n-methyl-propanamine)-3-(2-naphtol) thiophene, an imputity of duloxetine hydrochloride
12/12/2007EP1863779A1 Addition salts of tolperisone, processes for their preparation and use thereof
12/12/2007EP1863778A2 Spirocyclic thrombin receptor antagonists
12/12/2007EP1863777A1 1,2,4 -triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors
12/12/2007EP1863776A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations
12/12/2007EP1863772A1 Amide derivatives as ppar activators
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1863769A2 Hsp90 inhibitors, methods of making and uses therefor
12/12/2007EP1863768A1 Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester
12/12/2007EP1863767A1 Metabolites for nk-i antagonists for emesis
12/12/2007EP1863766A2 Certain substituted amides, method of making, and method of use thereof
12/12/2007EP1863763A1 3,4,5-substituted piperidines as renin inhibitors
12/12/2007EP1863762A1 Indole derivatives and methods of using the same
12/12/2007EP1863757A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/12/2007EP1863753A2 Trihydroxy polyunsaturated eicosanoid derivatives
12/12/2007EP1863748A1 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
12/12/2007EP1863573A1 Treatment of laminitis
12/12/2007EP1863572A2 New class of t cells activators and use thereof
12/12/2007EP1863571A1 Compounds for inhibiting ksp kinesin activity
12/12/2007EP1863562A2 Method of treating depression, mood disorders and anxiety disorders using neuromodulation
12/12/2007EP1863536A1 Synthetic anti-candida albicans oligosaccharide based vaccines
12/12/2007EP1863535A1 Endoparasiticide
12/12/2007EP1863534A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor
12/12/2007EP1863533A1 Combination of interleukin-6 antagonists and antiproliferative drugs
12/12/2007EP1863522A2 Compounds having activity in correcting mutant-cftr processing and uses thereof
12/12/2007EP1863520A1 Use of interleukin 17e for the treatment of cancer
12/12/2007EP1863516A2 Compositions and methods involving mda-7 for the treatment of cancer
12/12/2007EP1863510A1 Methods for treating parkinson's disease
12/12/2007EP1863508A2 Morinda citrifolia based antifungal formulations and methods
12/12/2007EP1863500A2 Hepatitis c therapies
12/12/2007EP1863499A1 Method for inhibiting and/or treating vaginal infection
12/12/2007EP1863498A2 Composition comprising isoorientin for suppressing histamine
12/12/2007EP1863497A2 Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
12/12/2007EP1863495A1 Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
12/12/2007EP1863494A1 Use of vitamin d compounds to treat endometriosis
12/12/2007EP1863493A1 Corticosteroid containing formulation for treating psoriasis, eczema, ulcer and burns.
12/12/2007EP1863492A1 Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
12/12/2007EP1863491A1 Pharmaceutical combination of bcr-abl and raf inhibitors
12/12/2007EP1863490A2 Muscarinic modulators
12/12/2007EP1863489A1 Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent
12/12/2007EP1863488A2 Use of amino-substituted 8-n-benzimidazoles
12/12/2007EP1863487A2 Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands
12/12/2007EP1863486A2 Treatment of epilepsy with non-imidazole alkylamines histamine h3-receptor ligands
12/12/2007EP1863485A2 Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions
12/12/2007EP1863484A1 Substituted triazole derivatives as oxytocin antagonists
12/12/2007EP1863483A1 Bicyclic pyrazole compounds as antibacterial agents
12/12/2007EP1863482A1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage
12/12/2007EP1863481A1 Methods for administering ixabepilone
12/12/2007EP1863480A1 Compounds having immunomodulator activity
12/12/2007EP1863479A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators cross reference to related applications
12/12/2007EP1863478A2 Indoloquinone tumor radiation sensitization
12/12/2007EP1863477A1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
12/12/2007EP1863476A1 The combination of anticholinergics and leukotriene receptor antagonists for the treatment of repiratory diseases
12/12/2007EP1863475A2 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
12/12/2007EP1863474A1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
12/12/2007EP1863473A1 Novel use of lignan compounds
12/12/2007EP1863472A2 Amino acid composition for improving glucose tolerance
12/12/2007EP1863471A1 Use of angelic acid esters as an antiphlogistic active ingredient and antiphlogistic preparations
12/12/2007EP1863470A1 A method for preventing and/or treating vaginal and vulval infections
12/12/2007EP1863469A1 A topical analgesic composition
12/12/2007EP1863468A1 A topical anaesthetic composition
12/12/2007EP1863467A2 Combination of organic compounds
12/12/2007EP1863466A2 Synergistic salivation components
12/12/2007EP1863465A1 Compositions for oral transmucosal delivery of metformin
12/12/2007EP1863464A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
12/12/2007EP1863463A1 Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substitued by amino and phenyl groups
12/12/2007EP1863462A2 Treatment of eye disorders with sirtuin modulators
12/12/2007EP1863461A2 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
12/12/2007EP1863460A2 Solubilized ibuprofen
12/12/2007EP1863455A1 New pharmaceutical compositions useful in the treatment of parkinson's disease
12/12/2007EP1863454A2 New pharmaceutical compositions useful in the treatment of migraine
1 ... 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 ... 7860